PORTAGE LEARNING NURS 251
PHARMACOLOGY FINAL EXAM BUNDLE
QUESTIONS AND DEEP RATIONALES
PROFESSOR STEPP
This premium study bundle contains the complete repository of high-yield
pharmacology exam questions and answers meticulously tailored to
Professor Stepp’s syllabus. Every question delivers a direct correct answer
followed by a comprehensive, deep-dive analytical rationale explaining core
pharmacokinetics, disease pathophysiology, and weight-based dosing
calculations. It is the ultimate resource designed to help students master
complex drug interactions and achieve top-tier marks on their proctored
final exams.
Question 1
A nurse is preparing to administer an oral medication that is classified as a
weak acid. In which environment will this drug be absorbed most
efficiently?
A) The alkaline environment of the duodenum
B) The acidic environment of the stomach
C) The neutral environment of the lower jejunum
D) The mucosal lining of the colon
Answer: B
Rationale: According to the principles of pharmacokinetics, weak acids
remain in their non-ionized (lipid-soluble) state when exposed to an acidic
environment like the stomach. Non-ionized drugs cross cellular membranes
much more rapidly than ionized drugs, maximizing absorption efficiency
before reaching the intestines.
,Question 2
A patient is prescribed a new medication that acts as a competitive
antagonist. Which statement best describes the mechanism of action of this
drug?
A) It binds irreversibly to the receptor site, permanently preventing agonist
binding.
B) It binds to an allosteric site, altering the shape of the receptor
permanently.
C) It binds to the active receptor site reversibly, competing directly with
endogenous agonists.
D) It stimulates the receptor directly to produce a submaximal physiological
response.
Answer: C
Rationale: Competitive antagonists bind reversibly to the exact same
active site as the endogenous agonist. Their blocking effect can be
overcome or overridden by increasing the concentration of the agonist at
the receptor site, which distinguishes them from non-competitive or
irreversible antagonists.
Question 3
During a pharmacology lecture, the instructor notes that a specific drug has
a high first-pass effect. Which route of administration should the nurse
expect to bypass this effect completely?
A) Oral tablet
B) Sublingual tablet
C) Rectal suppository
D) Nasogastric tube delivery
Answer: B
Rationale: The sublingual route allows the medication to be absorbed
directly through the oral mucosa into the systemic venous circulation,
bypassing the portal vein and liver entirely. Oral and nasogastric
,administrations drain directly into the portal circulation, subjecting the drug
to hepatic metabolism (first-pass effect) before reaching systemic blood
flow. Rectal administration only partially bypasses it.
Question 4
A physician orders a loading dose of an intravenous antibiotic for a patient
with sepsis. What is the primary clinical purpose of administering a loading
dose?
A) To minimize the risk of drug-induced toxicities and adverse reactions
B) To bypass hepatic metabolism and decrease the drug's half-life
C) To rapidly achieve a therapeutic steady-state concentration in the
plasma
D) To ensure the drug remains highly bound to plasma albumin molecules
Answer: C
Rationale: A loading dose is a larger initial dose given to rapidly raise the
plasma drug concentration to a therapeutic level (steady state). Without a
loading dose, it typically takes four to five half-lives of regular maintenance
dosing to reach steady-state equilibrium.
Question 5
A nurse is calculating the weight-based dose of a medication for a pediatric
patient weighing 44 pounds. The ordered dose is 15 mg/kg/day divided into
two equal doses. How many milligrams should the patient receive per
single dose?
A) 150 mg
B) 300 mg
C) 440 mg
D) 600 mg
Answer: A
Rationale: First, convert the patient's weight from pounds to kilograms: 44
lbs ÷ 2.2 = 20 kg. Next, calculate the total daily dose required: 20 kg × 15
, mg/kg/day = 300 mg/day. Finally, divide the total daily dose by two for the
individual dose amount: 300 mg ÷ 2 = 150 mg per dose.
Question 6
A patient with a history of severe chronic obstructive pulmonary disease
(COPD) is diagnosed with Stage 2 Hypertension. Which antihypertensive
medication class is contraindicated for this patient?
A) Calcium Channel Blockers
B) Angiotensin-Converting Enzyme (ACE) Inhibitors
C) Non-selective Beta-Blockers
D) Thiazide Diuretics
Answer: C
Rationale: Non-selective beta-blockers (such as propranolol) block both
Beta-1 and Beta-2 adrenergic receptors. Blocking Beta-2 receptors in the
lungs causes bronchoconstriction, which can trigger severe, life-threatening
airway resistance or asthma attacks in patients with underlying respiratory
conditions like COPD.
Question 7
A nurse is reviewing the lab results of a patient taking an ACE inhibitor.
Which electrolyte imbalance must the nurse actively monitor for?
A) Hypokalemia
B) Hyperkalemia
C) Hyponatremia
D) Hypocalcemia
Answer: B
Rationale: ACE inhibitors block the conversion of Angiotensin I to
Angiotensin II, which subsequently suppresses the secretion of aldosterone
from the adrenal cortex. Because aldosterone promotes sodium retention
and potassium excretion, blocking it leads to sodium loss and potassium
retention, increasing the risk of hyperkalemia.
PHARMACOLOGY FINAL EXAM BUNDLE
QUESTIONS AND DEEP RATIONALES
PROFESSOR STEPP
This premium study bundle contains the complete repository of high-yield
pharmacology exam questions and answers meticulously tailored to
Professor Stepp’s syllabus. Every question delivers a direct correct answer
followed by a comprehensive, deep-dive analytical rationale explaining core
pharmacokinetics, disease pathophysiology, and weight-based dosing
calculations. It is the ultimate resource designed to help students master
complex drug interactions and achieve top-tier marks on their proctored
final exams.
Question 1
A nurse is preparing to administer an oral medication that is classified as a
weak acid. In which environment will this drug be absorbed most
efficiently?
A) The alkaline environment of the duodenum
B) The acidic environment of the stomach
C) The neutral environment of the lower jejunum
D) The mucosal lining of the colon
Answer: B
Rationale: According to the principles of pharmacokinetics, weak acids
remain in their non-ionized (lipid-soluble) state when exposed to an acidic
environment like the stomach. Non-ionized drugs cross cellular membranes
much more rapidly than ionized drugs, maximizing absorption efficiency
before reaching the intestines.
,Question 2
A patient is prescribed a new medication that acts as a competitive
antagonist. Which statement best describes the mechanism of action of this
drug?
A) It binds irreversibly to the receptor site, permanently preventing agonist
binding.
B) It binds to an allosteric site, altering the shape of the receptor
permanently.
C) It binds to the active receptor site reversibly, competing directly with
endogenous agonists.
D) It stimulates the receptor directly to produce a submaximal physiological
response.
Answer: C
Rationale: Competitive antagonists bind reversibly to the exact same
active site as the endogenous agonist. Their blocking effect can be
overcome or overridden by increasing the concentration of the agonist at
the receptor site, which distinguishes them from non-competitive or
irreversible antagonists.
Question 3
During a pharmacology lecture, the instructor notes that a specific drug has
a high first-pass effect. Which route of administration should the nurse
expect to bypass this effect completely?
A) Oral tablet
B) Sublingual tablet
C) Rectal suppository
D) Nasogastric tube delivery
Answer: B
Rationale: The sublingual route allows the medication to be absorbed
directly through the oral mucosa into the systemic venous circulation,
bypassing the portal vein and liver entirely. Oral and nasogastric
,administrations drain directly into the portal circulation, subjecting the drug
to hepatic metabolism (first-pass effect) before reaching systemic blood
flow. Rectal administration only partially bypasses it.
Question 4
A physician orders a loading dose of an intravenous antibiotic for a patient
with sepsis. What is the primary clinical purpose of administering a loading
dose?
A) To minimize the risk of drug-induced toxicities and adverse reactions
B) To bypass hepatic metabolism and decrease the drug's half-life
C) To rapidly achieve a therapeutic steady-state concentration in the
plasma
D) To ensure the drug remains highly bound to plasma albumin molecules
Answer: C
Rationale: A loading dose is a larger initial dose given to rapidly raise the
plasma drug concentration to a therapeutic level (steady state). Without a
loading dose, it typically takes four to five half-lives of regular maintenance
dosing to reach steady-state equilibrium.
Question 5
A nurse is calculating the weight-based dose of a medication for a pediatric
patient weighing 44 pounds. The ordered dose is 15 mg/kg/day divided into
two equal doses. How many milligrams should the patient receive per
single dose?
A) 150 mg
B) 300 mg
C) 440 mg
D) 600 mg
Answer: A
Rationale: First, convert the patient's weight from pounds to kilograms: 44
lbs ÷ 2.2 = 20 kg. Next, calculate the total daily dose required: 20 kg × 15
, mg/kg/day = 300 mg/day. Finally, divide the total daily dose by two for the
individual dose amount: 300 mg ÷ 2 = 150 mg per dose.
Question 6
A patient with a history of severe chronic obstructive pulmonary disease
(COPD) is diagnosed with Stage 2 Hypertension. Which antihypertensive
medication class is contraindicated for this patient?
A) Calcium Channel Blockers
B) Angiotensin-Converting Enzyme (ACE) Inhibitors
C) Non-selective Beta-Blockers
D) Thiazide Diuretics
Answer: C
Rationale: Non-selective beta-blockers (such as propranolol) block both
Beta-1 and Beta-2 adrenergic receptors. Blocking Beta-2 receptors in the
lungs causes bronchoconstriction, which can trigger severe, life-threatening
airway resistance or asthma attacks in patients with underlying respiratory
conditions like COPD.
Question 7
A nurse is reviewing the lab results of a patient taking an ACE inhibitor.
Which electrolyte imbalance must the nurse actively monitor for?
A) Hypokalemia
B) Hyperkalemia
C) Hyponatremia
D) Hypocalcemia
Answer: B
Rationale: ACE inhibitors block the conversion of Angiotensin I to
Angiotensin II, which subsequently suppresses the secretion of aldosterone
from the adrenal cortex. Because aldosterone promotes sodium retention
and potassium excretion, blocking it leads to sodium loss and potassium
retention, increasing the risk of hyperkalemia.
